APA (7th ed.) Citation

Rosenson, R. S., Wolff, D. A., Huskin, A. L., Helenowski, I. B., & Rademaker, A. W. (2007). Fenofibrate Therapy Ameliorates Fasting and Postprandial Lipoproteinemia, Oxidative Stress, and the Inflammatory Response in Subjects With Hypertriglyceridemia and the Metabolic Syndrome. Diabetes care, 30(8), 1945-1951. https://doi.org/10.2337/dc07-0015

Chicago Style (17th ed.) Citation

Rosenson, Robert S., David A. Wolff, Anna L. Huskin, Irene B. Helenowski, and Alfred W. Rademaker. "Fenofibrate Therapy Ameliorates Fasting and Postprandial Lipoproteinemia, Oxidative Stress, and the Inflammatory Response in Subjects With Hypertriglyceridemia and the Metabolic Syndrome." Diabetes Care 30, no. 8 (2007): 1945-1951. https://doi.org/10.2337/dc07-0015.

MLA (9th ed.) Citation

Rosenson, Robert S., et al. "Fenofibrate Therapy Ameliorates Fasting and Postprandial Lipoproteinemia, Oxidative Stress, and the Inflammatory Response in Subjects With Hypertriglyceridemia and the Metabolic Syndrome." Diabetes Care, vol. 30, no. 8, 2007, pp. 1945-1951, https://doi.org/10.2337/dc07-0015.